Startup Seattle-area longevity company emerges from three startups, plans to go public via SPAC – StartupJanuary 27, 20230 Longevity Biomedical CEO Bradford Zakes. (Longevity Photograph) Bradford Zakes just lately helped mix the Seattle-area biotech firm he led, Cerevast…
